Notice of Retraction: Duplication in “Targeted Molecular Therapy in Melanoma” (Semin Cutan Med Surg. 2010;29:196-201)
Igor Puzanov, MD, MSCI; Keith T. Flaherty, MD
doi:10.12788/j.sder.2020.001
Published September 2020

We regret that a significant portion of our article “Targeted Molecular Therapy in Melanoma”¹ published in the September 2010 issue of Seminars in Cutaneous Medicine and Surgery was a duplication of another article, “B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant Melanoma,” co-authored by Dr. Puzanov² and published in the May 2010 issue of Current Oncology Reports. We regret the duplication of the article¹ caused by a submission error. Given that Dr. Puzanov was the only overlapping author, Drs. Flaherty, Sosman, and Shepherd would have had no knowledge and no way of checking, as the initial article had not yet been published or was just published in Current Oncology Reports at the time of the submission of the article published in Seminars in Cutaneous Medicine and Surgery. Thus the error was not discovered at the time of submission. Therefore, we retract the article¹ from the literature.

The editors of Seminars in Cutaneous Medicine and Surgery agree with the retraction of this article.

References
1. Puzanov I, Flaherty KT. Targeted molecular therapy in melanoma. Semin Cutan Med Surg. 2010;29:196-201.
2. Shepherd C, Puzanov I, Sosman JA. B-RAF inhibitors: an evolving role in the therapy of malignant melanoma. Curr Oncol Rep. 2010;12:146-152.